GVAX consists of two genetically modified and irradiated allogeneic pancreatic tumor cell lines that secrete granulocyte–macrophage colony-stimulating factor (GM-CSF), which can stimulate dendritic cell differentiation, activation, and migration [35]. This evidence concerns the gene CSF2 and pancreatic neoplasm.